CA 19-9 fasting state
Selected indexed studies
- Serum CA 19-9 Level is Correlated to the Clinical Characteristics and Chronic Complications of Patients Newly Diagnosed with Type 2 Diabetes Mellitus. (Exp Clin Endocrinol Diabetes, 2021) [PMID:31461764]
- Type 2 diabetes mellitus and CA 19-9 levels. (World J Gastroenterol, 2007) [PMID:17879406]
- Relationship between CA 19-9 levels and glucose regulation in a middle-aged and elderly Chinese population. (J Diabetes, 2012) [PMID:22176810]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Serum CA 19-9 Level is Correlated to the Clinical Characteristics and Chronic Complications of Patients Newly Diagnosed with Type 2 Diabetes Mellitus. (2021) pubmed
- Type 2 diabetes mellitus and CA 19-9 levels. (2007) pubmed
- Relationship between CA 19-9 levels and glucose regulation in a middle-aged and elderly Chinese population. (2012) pubmed
- Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes. (2010) pubmed
- Clinical implication of elevated CA 19-9 level and the relationship with glucose control state in patients with type 2 diabetes. (2014) pubmed
- CA 19-9 is associated with poor glycemic control in diabetic patients: role of insulin resistance. (2014) pubmed
- Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection. (2003) pubmed
- Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer. (2002) pubmed
- Influence of metabolic disturbances of diabetes mellitus on serum CA 19-9 tumor marker. (1991) pubmed
- Effect of glycotoxicity and lipotoxicity on carbohydrate antigen 19 - 9 in the patients with diabetes. (2024) pubmed